PRIME DIABETES DRUGS OBESITY
Aeg41-1002	Dr. Michael Burgess Says Get Rid of FDA Green List: Its a Vulnerability for American Patients
	Quote:	As weight loss drugs such as Ozempic, Mounjaro, Wegovy, and Zepbound (also known as GLP-1s) increased in popularity a surge Burgess notes as a positive, because these drugs are effective and they are approved by the FDA and manufactured under its oversight the country began to see a shortage of them. A recent Gallup analysis found that the portion of American adults currently taking GLP-1s for weight loss rose to 11 percent in 2026, up significantly from 3 percent in 2024. Due to shortages of the medication, some people began seeking out the active pharmaceutical ingredients (APIs) in GLP-1s from unapproved manufacturers. To alleviate the problem quickly, the FDA rolled out a "green list" of pre-approved manufacturers in other countries that could import their drugs into the United States without going through traditional customs methods that other foreign drugs go through.... China is the most heavily represented country by far. Earlier this year, one of the Chinese manufacturers on the FDA green list was caught sourcing an unapproved API known as semaglutide from a facility that was not on the list, and putting its own label on it before shipping it to the United States. The manufacturer, called Harbin Jixianglong Biotech, is also accused of altering manufacturing and retesting information before the product was used by patients across the United States.
	Article:	https://www.breitbart.com/health/2026/10/09/exclusive-rx-border-defenses-dr-michael-burgess-says-get-rid-of-fda-green-list-its-vulnerability-american-patients/
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
PRIME DIABETES DRUGS OBESITY
Sd412-010	Popular Weight Loss Drugs Linked to a Surprising Fingernail Problem
	Quote:	Popular GLP-1 medications used for weight loss and type 2 diabetes (such as Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, and Trulicity) have been linked to an unexpected problem involving fingernails. A multinational study found that people taking these drugs were more than four times as likely to report nail detachment, a condition in which the nail separates from the skin underneath it. Researchers found that 39 of GLP-1 users experienced nail detachment, compared with just 9 of people who had never taken the medications. Nail discoloration was also considerably more common, and two-thirds (66) of users reported at least one nail disorder.
	Article:	https://www.sciencedaily.com//releases/2026/10/261011211604.htm
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
PRIME COGNITION DIABETES DRUGS EYES OBESITY
Sd413-001	Ozempic and Wegovy Linked to Rare Risk of Sudden Vision Loss
	Quote:	Popular diabetes and weight loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss.
	Comment:	Weight loss drug Fen-Pfen all over again?
	Article:	https://www.sciencedaily.com//releases/2026/10/261014015521.htm
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
DIABETES PHYSICAL
Sd413-006	Scientists Reveal Why Some Workout Recovery Tricks Can Backfire
	Quote:	Scientists say the most effective recovery methods are far simpler and cheaper: getting enough sleep, eating well, and giving muscles time to rebuild.
	Article:	https://www.sciencedaily.com//releases/2026/10/261013015805.htm
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho

Javilk's Research Links Newsletter for Week 41
Updated 10/17/2026-02:05:55 AM
Back Issue Topic Map
What interests you? What have you found? Tell me!
Drop me a note at Javilk.com to subscribe or submit something.

Aeg41-1002

Dr. Michael Burgess Says Get Rid of FDA Green List: Its a Vulnerability for American Patients

Sd412-010

Popular Weight Loss Drugs Linked to a Surprising Fingernail Problem

Sd413-001

Ozempic and Wegovy Linked to Rare Risk of Sudden Vision Loss

Sd413-006

Scientists Reveal Why Some Workout Recovery Tricks Can Backfire